How are the CEA test results and cancer stage related?

CEA, or carcinoembryonic antigen, is used in diagnosing and monitoring certain types of cancer due to its ability to rise when cancer is present. It has been proven to be an effective way of determining the stage and progression of cancer within a patient.

When measuring CEA levels, it is important to understand how they are related to specific stages of cancer. The results can provide insight into the size and extent of the tumor(s) within the body. For example, increased levels may indicate early-stage (1 or 2) cancers while lower levels tend to signify more advanced stages (3 or 4). Additionally, rising CEA levels between two tests may mean that there is potential for rapid growth and spreading; whereas declining values can indicate that treatment is working as hoped for.

A physician should assess all factors related to an individual’s medical history before making any definitive diagnoses based on CEA test results alone. However, it has been found that understanding these values can be helpful in determining both the current state and likely future progression of various cancers in many patients.